Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker.
Curr Opin Colloid Interface Sci
; 51: 101413, 2021 Feb.
Article
em En
| MEDLINE
| ID: mdl-33390762
ARDS; COVID-19; Collectin; Pulmonary surfactant; SARS-CoV-2; Toll-like receptor, TLR; acute respiratory distress syndrome, ARDS; angiotensin-converting enzyme 2, ACE2; coronavirus disease 2019, COVID-19; dipalmitoylphosphatidylcholine, DPPC; human immunodeficiency virus, HIV; interleukin, IL; palmitoyl-oleoyl-phosphatidylglycerol, POPG; phosphatidylinositol, PI; respiratory distress syndrome, RDS; severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; surfactant proteins, SP; tumor necrosis factor, TNF
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Curr Opin Colloid Interface Sci
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Índia